Sergi Clavé

Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples

David Casadevall, Sergi Clavé, Álvaro Taus et al. · Clinical Lung Cancer · 2017 · 84 citations

Cancer Immunosurveillance, Malignant Disease, Medicine +10

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)

David Casadevall, Javier Gimeno, Sergi Clavé et al. · Oncotarget · 2015 · 57 citations · Full text

Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma

Álvaro Taus, Laura Camacho, Pedro Rocha et al. · Clinical Lung Cancer · 2018 · 49 citations

Egfr Mutation Load, Oncology, Tumor Heterogeneity +11

HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer

Aïda Sampera, Francisco Javier Sánchez-Martín, Oriol Arpí et al. · Molecular Cancer Therapeutics · 2019 · 49 citations · Full text

Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non–small-cell Lung Cancer: Implications of FISH-positive Patterns

Sergi Clavé, Natàlia Rodón, Lara Pijuán et al. · Clinical Lung Cancer · 2019 · 36 citations

Non–small-cell Lung Cancer, Ros1 Rearrangement Detection, Oncology +9